✦ LIBER ✦

A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors

✍ Scribed by Tolcher, Anthony W.; Rodrigueza, Wendi V.; Rasco, Drew W.; Patnaik, Amita; Papadopoulos, Kyriakos P.; Amaya, Alex; Moore, Timothy D.; Gaylor, Shari K.; Bisgaier, Charles L.; Sooch, Mina P.; Woolliscroft, Michael J.; Messmann, Richard A.

Book ID: 121560486
Publisher: Springer
Year: 2013
Tongue: English
Weight: 692 KB
Volume: 73
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-013-2361-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

620 A Study of PNT2258 (DNA-targeted Blo

620 A Study of PNT2258 (DNA-targeted Blocker of BCL2 Expression) in Patients with Advanced Solid Tumors

✍ Rasco, D.W.; Patnaik, A.; Amaya, A.; Gaylor, S.; Moore, T.; Izbicka, E.; Streepe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Phase 1 study of MLN8054, a selective in

Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors

✍ E. Claire Dees; Jeffrey R. Infante; Roger B. Cohen; Bert H. O’Neil; Suzanne Jone 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 328 KB

Phase 1 study of the investigational, or

Phase 1 study of the investigational, oral angiogenesis inhibitor motesanib in Japanese patients with advanced solid tumors

✍ Yasuhito Fujisaka; Yasuhide Yamada; Noboru Yamamoto; Toshio Shimizu; Yutaka Fuji 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 364 KB

A phase I clinical trial of navitoclax,

A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumors

✍ Cleary, James M.; Lima, Caio Max S. Rocha; Hurwitz, Herbert I.; Montero, Alberto 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 408 KB

A phase I, first-in-human dose-escalatio

A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors

✍ Raoul Tibes, Gil Fine, Gavin Choy, Sanjeev Redkar… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 232 KB

A phase 1 study of gemcitabine combined

A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors

✍ David S. Hong, Jennifer Hsing Choe, Aung Naing, Jennifer J. Wheler, Gerald S. Fa 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 335 KB